Dr. Mohammad A. Ansari, M.D.
Pulmonology (Pulmonary Disease Physician)
6310 San Vicente Blvd, Suite 280
Los Angeles, CA 90048
Who else practices at this address →
Los Angeles County includes primary care (7% of residents) and mental health (13% of residents) shortage areas. About shortage areas
- Medicare participating
At a glance
- Medical school
- University of California, Irvine, California College of Medicine (1991)
- Years since graduation
- 35
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 753
Licensed in California since 1992, according to the Medical Board of California. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1991Medical school: University of California, Irvine, California College of Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Pulmonary Disease Physician primary
CA license G75046 (first issued 1992; current)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Cedars-Sinai Medical Center Los Angeles, CA
- Ronald Reagan UCLA Medical Center Los Angeles, CA
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 753
- Services billed
- 3,890
- Patients’ average age
- 78
| Service | Times | Patients |
|---|---|---|
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 1,007 | 152 |
| Established patient office or other outpatient visit, 30-39 minutes | 582 | 348 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 555 | 110 |
| Test to examine how well the lungs exchange gases | 214 | 212 |
| Test to determine lung volumes using gas dilution or washout | 211 | 209 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 192 | 145 |
| Established patient office or other outpatient visit, 40-54 minutes | 166 | 129 |
| New patient office or other outpatient visit, 60-74 minutes | 166 | 166 |
| Established patient office or other outpatient visit, 20-29 minutes | 133 | 112 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 119 | 119 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Trelegy Ellipta (fluticasone/umeclidin/vilanter) Other prescribers in Los Angeles, CA | 315 |
| Albuterol Sulfate Hfa (albuterol sulfate) Other prescribers in Los Angeles, CA | 168 |
| Montelukast Sodium Other prescribers in Los Angeles, CA | 137 |
| Ventolin Hfa (albuterol sulfate) Other prescribers in Los Angeles, CA | 119 |
| Famotidine Other prescribers in Los Angeles, CA | 80 |
| Anoro Ellipta (umeclidinium brm/vilanterol tr) Other prescribers in Los Angeles, CA | 61 |
| Azelastine Hcl Other prescribers in Los Angeles, CA | 58 |
| Azithromycin Other prescribers in Los Angeles, CA | 55 |
| Vascepa (icosapent ethyl) Other prescribers in Los Angeles, CA | 51 |
| Breztri Aerosphere (budesonide/glycopyr/formoterol) Other prescribers in Los Angeles, CA | 44 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 13 companies reported 56 payments worth $1,386 in total to this clinician.
| Insmed, Inc. | $266 |
|---|---|
| GlaxoSmithKline, LLC. | $223 |
| Jazz Pharmaceuticals Inc. | $204 |
| Regeneron Healthcare Solutions, Inc. | $183 |
| Abiomed | $148 |
| Lilly USA, LLC | $76.97 |
| Viatris Specialty LLC | $66.99 |
| Sumitomo Pharma America, Inc. | $53.96 |
| Food and Beverage | $1,111 |
|---|---|
| Education | $275 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. Apr 7, 2025 | Education DUPIXENT · IMMUNOLOGY AND INFLAMMATION · in-kind | $94.63 |
| Jazz Pharmaceuticals Inc. Aug 25, 2025 | Education XYWAV · NEUROLOGY · in-kind | $90.00 |
| Jazz Pharmaceuticals Inc. Aug 6, 2025 | Education XYWAV · NEUROLOGY · in-kind | $90.00 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.